Matrix metalloproteinases, tissue inhibitors of metalloproteinases, and glycosaminoglycans in synovial fluid from patients with rheumatoid arthritis

Journal of Rheumatology

Volumn 26, Issue 1, 1999, Pages 34-40

  Ishiguro, Naoki ^a   Ito, Takayasu ^b   Miyazaki, Kyousuke ^b   Iwata, Hisashi ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Glycosaminoglycan; Matrix metalloproteinase; Synovial fluid; Tissue inhibitor of metalloproteinase

Indexed keywords

AUROTHIOMALATE; BUCILLAMINE; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; GELATINASE A; GELATINASE B; GLYCOSAMINOGLYCAN; HYALURONIC ACID; KERATAN SULFATE; MATRIX METALLOPROTEINASE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; SALAZOSULFAPYRIDINE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; AGED; ARTICLE; CARTILAGE MATRIX; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

AGED; ARTHRITIS, RHEUMATOID; CHONDROITIN SULFATES; FEMALE; GLYCOSAMINOGLYCANS; HUMANS; HYALURONIC ACID; KERATAN SULFATE; MALE; METALLOENDOPEPTIDASES; MIDDLE AGED; SYNOVIAL FLUID; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0032943671     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Mainardi CL. Biochemical mechanisms of articular destruction. Rheum Dis Clin North Am 1987;13:215-33.
2. Harris EJ. Rheumatoid arthritis: pathophysiology and implications for therapy. New Engl J Med 1990;322:1277-89.
3. Vincenti MP, Clark IM, Brinckerhoff CE. Using inhibitors of metalloproteinases to treat arthritis. Easier said than done? Arthritis Rheum 1994;37:1115-26.
4. Ito A, Nagase H. Evidence that human rheumatoid synovial matrix metalloproteinase 3 is an endogenous activator of procollagenase 1. Arch Biochem Biophys 1988;267:211-6.
5. Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H. Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis 1989;48:645-53.
6. Cole AA, Kuettner KE. MMP-8 (neutrophil collagenase) mRNA and aggrecanase cleavage products are present in normal and osteoarthritic human articular cartilage. Acta Orthop Scand 1995; Suppl 266:98-102.
7. Lindy O, Konttinen YT, Sorsa T, et al. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum 1997;40:1391-9.
8. Apte SS, Olsen BR, Murphy G. The gene structure of tissue inhibitor of metalloproteinases (TIMP)-3 and its inhibitory activities define the distinct TIMP gene family. J Biol Chem 1995;270:14313-8.
9. Leco KJ, Apte SS, Taniguchi GT, et al. Murine tissue inhibitor of metalloproteinases-4 (TIMP-4): cDNA isolation and expression in adult mouse tissues. FEBS Letts 1997;401:213-7.
10. Hembry RM, Bagga MR, Murphy G, Henderson B, Reynolds JJ. Rabbit models of arthritis: immunolocalization of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage. Am J Pathol 1993;143:628-42.
11. Martel PJ, McCollum R, Fujimoto N, Obata K, Cloutier JM, Pelletier JP. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis. Lab Invest 1994;70:807-15.
12. Fawthrop F, Yaqub R, Belcher C, Bayliss M, Ledingham J, Doherty M. Chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in progressive versus non-progressive osteoarthritis. Ann Rheum Dis 1997;56:119-22.
13. Belcher C, Yaqub R, Fawthrop F, Bayliss M, Doherty M. Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees. Ann Rheum Dis 1997;56:299-307.
14. Mourao PAS. Distribution of chondroitin 4-sulfate and chondroitin 6-sulfate in human articular and growth cartilage. Arthritis Rheum 1988;31:1028-33.
15. Shinmei M, Miyauchi S, Machida A, Miyazaki K. Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid. Arthritis Rheum 1992;35:1304-8.
16. Thonar EJ-MA, Kuettner KE, Williams JM. Markers of articular cartilage injury and healing. In: Andrish JT, editor. Sports medicine & arthroscopy review: Chondral injuries. New York: Raven Press; 1994:13-28.
17. Kodama S, Iwata K, Iwata H, Yamashita K, Hayakawa T. Rapid one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases. J Immunol Methods 1990;127:103-8.
18. Fujimoto N, Zhang J, Iwata K, Shinya T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinases-2 using monoclonal antibodies. Clin Chim Acta 1993;220:31-45.
19. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72 kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 1993;221:91-103.
20. Obata K, Iwata K, Okada Y, et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta 1992;211:59-72.
21. Fujimoto N, Hosokawa N, Iwata K, Shinya T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. Clin Chim Acta 1994;231:79-88.
22. Larsen A, Dale K, Eek M. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta Radiol Diagnosis 1977;18:481-91.
23. Ishiguro N, Takayasu Ito, Ken-ichi Obata, Fujimato N, Iwata H. Determination of stromelysin-1, 72 and 92 kDa Type IV collagenase, tissue inhibitor of metalloproteinase-1 (TIMP-1), and TIMP-2 in synovial fluid and serum from patients with rheumatoid arthritis. J Rheumatol 1996;23:1599-604.
24. Koolwijk P, Miltenburg AM, van Erck MG, et al. Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. J Rheumatol 1995;22:385-93.
25. Xie DL, Hui F, Meyers R, Homandberg GA. Cartilage chondrolysis by fibronectin fragments is associated with release of several proteinases: stromelysin plays a major role in chondrolysis. Arch Biochem Biophys 1994;311:205-12.
26. Fosang AJ, Last K, Knauper V, et al. Fibroblast and neutrophil collagenase cleave at two sites in the cartilage aggrecan interglobular domain. Biochem J 1993;295:273-6.
27. Laurent TC, Fraser JR, Laurent UB, Engstrom-Laurent A. Hyaluronan in inflammatory joint disease. Acta Orthop Scand 1995; Suppl 266:116-20.